Loading clinical trials...
Loading clinical trials...
A Pilot Study to Evaluate the Safety and Initial Effectiveness of the Cala ONE Device to Repeatably Aid in the Symptomatic Relief of Essential Tremor
Conditions
Interventions
Cala ONE device
Locations
4
United States
Personal Care Neurology
Oakland, California, United States
Movement & Neuroperformance Center
Denver, Colorado, United States
Kansas University Medical Center
Kansas City, Kansas, United States
EvergreenHealth
Kirkland, Washington, United States
Start Date
July 26, 2017
Primary Completion Date
March 8, 2018
Completion Date
March 8, 2018
Last Updated
April 30, 2019
NCT07417280
NCT04212780
NCT03984643
NCT01581580
NCT07056361
NCT01734122
Lead Sponsor
Cala Health, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions